pp 1-7 | Cite as
Vaccination Against Measles, Mumps, and Rubella in the Light of Current Epidemic Threats: Unjustified Postponement
A worrying increase in the number of measles cases has been noted recently in Poland, which may have to do with a decreasing proportion of children vaccinated against measles, mumps, and rubella (MMR) in the second year of life (<95%). For many years, MMR vaccination in children has been associated with a fear of allergy to eggs. This study seeks to define the reason and justification for postponing MMR vaccination in a population of children referred to the outpatient specialist immunization clinic. One hundred and thirty eight (138) children, mean 24.5 ± 26.6 months, with a history of past allergies, in whom the first-time MMR vaccination was delayed by family doctors for fear of allergic reactions, were enrolled into the study. The mean delay in a vaccine shot was 12.3 ± 26.9 months. There were 101 children who displayed a distinct allergy to the egg proteins, among other accompanying types of allergy. All of the 138 children were found eligible to receive MMR vaccine at the visit to the clinic. No early allergic responses were noticed in any of the children. There were negligible delayed allergic responses in six children, all from the egg allergy group. We conclude that MMR vaccination in children with egg allergy is safe and can be conducted on the outpatient basis without any specific precautions or safety measures. Delays in vaccination were unjustified and may jeopardize children’s health. There is a need for insightful education of primary care doctors concerning of MMR vaccination safety, particularly when allergy is suspected, to avoid unduly and potentially harmful delays.
KeywordsAllergy Egg proteins Immunization Measles MMR vaccine Vaccination Vaccine coverage rate
Conflicts of Interest
The authors declare no conflicts of interest concerning this article.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. A local Ethics Committee approved the study protocol.
The need to obtain the consent from individual participants or their guardians to be included in the study was waived by the Ethics Committee due to a retrospective nature of the study consisting of reviewing the medical history files only.
- Aickin R, Hill D, Kemp A (1994) Measles immunisation in children with allergy to egg. BMJ 309:223–225Google Scholar
- Ainsworth E, Debenham P, Carrol ED, Riordan FAI (2010) Referrals for MMR immunisation in hospital. Arch Dis Child 95:639–641Google Scholar
- Andersen DV, Jørgensen IM (2013) MMR vaccination of children with egg allergy is safe. Dan Med J 60(2):A4573Google Scholar
- Baxter DN (1996) Measles immunization in children with a history of egg allergy. Vaccine 14:131–134Google Scholar
- Cronin J, Scorr A, Russell S, McCoy S, Walsh S, O’Sullivan R (2012) A review of a paediatric emergency department vaccination programme for patients at risk of allergy/anaphylaxis. Acta Paediatr 101:941–945Google Scholar
- Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS, Edwards KM, Caubet JC, Engler RJ, Gold MS, Ponvert C, Demoly P, Sanchez-Borges M, Muraro A, Li JT, Rottem M, Rosenwasser LJ (2016) International Consensus (ICON): allergic reactions to vaccines. World Allergy Organ J 9(1):32Google Scholar
- ECDC (2018a) European center for disease prevention and control. Monthly measles and rubella monitoring report, October 2018. ECDC, Stockholm, pp 1–9Google Scholar
- ECDC (2018b) Communicable disease threats report. Week 41, 7–13 October 2018. https://ecdc.europa.eu/sites/portal/files/documents/communicable-disease-threats-report-13-oct-2018.pdf. Accessed on 4 Nov 2018
- ECDC (2018c) European center for disease prevention and control publications & data. https://ecdc.europa.eu/en/publications-data. Accessed on 4 Nov 2018
- Franceschini F, Bottau P, Caimmi S, Crisafulli G, Lucia L, Peroni D, Saretta F, Vernich M, Povesi Dascola C, Caffarelli C (2015) Vaccination in children with allergy to non-active vaccine components. Clin Transl Med 4:3Google Scholar
- Goodyear-Smith F, Wong F, Petousis-Harris H, Wilson E, Turner N (2005) Follow-up of MMR vaccination status in children referred to a pediatric immunization clinic on account of egg allergy. Hum Vaccin 1:118–122Google Scholar
- Herman JJ, Radin R, Schneiderman R (1983) Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. J Pediatr 102:196–199Google Scholar
- James JM, Burks AW, Roberson PK, Sampson HA (1995) Safe administration of the measles vaccine to children allergic to eggs. N Engl J Med 332:1262–1266Google Scholar
- Kelso JM (2014) Potential food allergens in medications. J Allergy Clin Immunol 133:1509–1518Google Scholar
- Kemp A, Van Asperen P, Mukhi A (1990) Measles immunization in children with clinical reactions to egg protein. Am J Dis Child 144:33–35Google Scholar
- Khakoo GA, Lack G (2000) Recommendations for using MMR vaccine in children allergic to eggs. BMJ 320:929–932Google Scholar
- O’Brien TC, Maloney CJ, Tauraso NM (1971) Quantitation of residual host protein in chicken embryo-derived vaccines by radial immunodiffusion. Appl Microbiol 21:780–782Google Scholar
- Patja A, Makinen-Kiljunen S, Davidkin I, Paunio M, Peltola H (2001) Allergic reactions to measles-mumps-rubella vaccination. Pediatrics 107(2):e27–e27Google Scholar
- PZH (2018) Preventive vaccinatins in Poland in 2017. http://wwwold.pzh.gov.pl/oldpage/epimeld/2017/Sz_2017_wstepne_dane.pdf. Accessed on 4 Nov 2018 (in Polish)